T he esophagus is the conduit for sustenance from the oral cavity to the stomach. Although it has a relatively simple task, its epithelial barrier and defects in the barrier can be a significant source of morbidity and in some cases mortality. To understand the pathophysiologic drivers of various disease states of the esophageal epithelial barrier, it is important to understand its development, anatomy, homeostasis, regenerative processes, and function at the microscopic level. It is also important to know the historical and state of the art techniques by which the epithelial barrier is studied from a structural and functional standpoint. In this overview, we discuss the anatomy and function of the esophageal epithelial barrier, along with its alterations in such conditions as eosinophilic esophagitis (EoE), erosive and nonerosive gastroesophageal reflux disease (GERD), and obesity.
Normal Anatomy

Development
During embryonic development, the esophagus develops from the foregut. It starts to take shape when the respiratory appendage, which consists of the lung buds and trachea, separates from the tissue via septation and elongation that becomes the esophagus. 1 The trachea develops pseudostratified columnar epithelium and becomes wrapped in stiff cartilage rings. The esophagus, however, undergoes a different endodermal and mesenchymal development. This results in a nonkeratinized stratified squamous epithelium that is surrounded by a combination of skeletal muscle in the proximal esophagus that transitions to smooth muscle in the distal esophagus.
During embryologic development, the lining of the esophagus goes through several stages. At first, it is lined with a thin layer of stratified columnar epithelium. 2 This lining morphs, starting at 8 weeks gestation, to include ciliated cells that cover the columnar epithelium. Later, at approximately 20 weeks, the ciliated cells and columnar epithelium are replaced by squamous epithelium. This metaplastic transformation results in a protective surface that is resistant to intraluminal insults, such as rough and hot food and limited amounts of refluxed noxious gastric contents.
Structure
This stratified squamous epithelium is made up of 3 distinct layers: (1) the stratum corneum (superficial cell layer), (2) the stratum spinosum (prickle cell layer), and (3) the stratum germinativum (basal cell layer) ( Figure 1 ). The deepest of these 3, the stratum germinativum, is typically 1-3 cells thick and is composed of immature-appearing cells with large nuclei and relatively small amount of cytoplasm. These cells are the only ones in the esophageal epithelium that are capable of mitosis, and they produce the daughter cells that migrate toward the lumen. During the migratory process, the nuclei shrink and eventually are lost, and the cell is eventually shed into the lumen. In rat models, this migration takes approximately 7 days. 3 
Barrier Function
The primary function of the barrier is to protect the deeper mucosal and submucosal layers from noxious intraluminal contents. This protective barrier function is composed of 3 main components that can be divided into pre-epithelial, epithelial, and postepithelial defenses. The pre-epithelial defenses at the luminal surface include an unstirred water layer and bicarbonate ions that are derived from swallowed saliva. 4 Esophageal submucosal glands also contribute water, bicarbonate, and mucin to this layer. 5 However this surface defense is not as robust as the one found in the stomach. As a result, the esophageal epithelium is more vulnerable to acid peptic injury and most of the protective function falls to the epithelial and postepithelial defenses.
Below the surface defenses is the stratum corneum, the most-apical of the cell layers, which is comprised of flat-shaped cells that enhance their lateral coverage. This shape is derived from a monomeric intracellular protein called filaggrin, which binds to and condenses the cellular cytoskeleton as cells migrate from the stratum spinosum to the stratum corneum. 6 In addition to the cells being compact in shape and allowing them to form protective squames, intercellular glycocalyx also provides an extra defense to paracellular transit.
However, the most important mechanism to defend against paracellular intrusion involves the complex that fuses the suprabasal layer of adjacent epithelial cells in the stratum corneum and spinosum. The structure that forms the fusion between cells and regulates the intercellular space diameter is known as the apical junction complex, and it includes 3 main components: (1) the tight junction complex, (2) the adherens junctions, and (3) the desmosomes.
The tight junction complex, the most apically located component of the apical junctional complex, interconnects cell membranes, actively regulates paracellular permeability of ions, and demarcates the boundary between basolateral and apical cell surface. The complex is made up of numerous proteins that span across the cell membranes and connect with the intracellular cytoskeleton. These proteins include claudin, occludin, zonulin, and junctional adhesion molecules (JAM), which are central proteins to tight junctions in most types of epithelia ( Figure 1) .
The transmembrane claudins are thought to be the key to barrier function, because claudin-1 knockout mice typically die within 24 hours of birth given loss of fluids and electrolytes through their epithelium. 7 Occludin is also thought to be critical in defining the barrier characteristic of the tight junction. 8 The zonulin proteins do not traverse the space between the cells but instead provide an intracellular foundation for the tight junction. There is a paucity of data that illustrate their role in tight junction regulation and thus paracellular transit in the esophagus. 9 Finally, the JAM protein also has a role in tight junction regulation. An in vitro study performed in a variety of human epithelia including intestine has shown that exposure to anti-JAM monoclonal antibodies results in a delay in occludin assembly, and decreased transepithelial resistance (TER; a measure of paracellular permeability). 10 Different mucosal linings have different expressions of these proteins, which results in varying degrees of paracellular permeability. Although not enough data exist about what the precise protein distributions are in the normal human esophagus, there are data that show that these proteins can be altered in number and distribution in different environments/pathologic processes, which is discussed later. 11, 12 The next intercellular structure that aids in cell-cell adhesion is the adherens junction. This structure is important in stabilizing the cell-cell adhesion, regulation of the intracellular actin cytoskeleton, mediating intracellular signaling, and transcription regulation. 13 The adherens junction is made up of the transmembrane protein epithelial-cadherin plus the intracellular components of p120-catenin, vinculin, a-catenin, and b-catenin.
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The most basal structure involved in cell-cell adhesion is the desmosome, which provides mechanical support to the adherens junction complex.
14 Given their role of maintaining cell-cell adhesion, both the adherens junction and desmosomes contribute to paracellular transit in an indirect fashion.
Hydrogen ions may be present in the esophagus as a result of gastroesophageal reflux. When hydrogen ions penetrate the cellular defenses as outlined previously, there are 2 additional levels of protection: a neutral intercellular glycoconjugate material that buffers paracellular hydrogen ions, 15 and the mucosal blood supply. In addition to providing nutrients and oxygen and removing metabolic byproducts, mucosal blood flow also defends against tissue destruction by removing not only hydrogen ions but also lactic acid and CO 2 . 4 It also delivers bicarbonate to the tissue to help with buffering. The role of blood supply as a defense against acidic reflux has been demonstrated in several studies that showed increase esophageal blood supply to the esophagus as it is exposed to luminal acid. 16, 17 Beyond defense, the esophageal epithelial cells that are exposed to a pathologic degree of reflux have the ability to repair in the form of restitution and replication. Maintaining barrier function with restitution involves the migration of adjacent viable cells to the cells that have undergone necrosis. 18, 19 This is an extremely rapid process, taking minutes to hours to accomplish. 20 Restitution can be seen as a quick repair, whereas replication takes days to weeks to occur. This process takes longer because of its dependence on mitosis, which is limited by the speed of DNA replication and protein synthesis. 21 The losing battle between the slow epithelial regeneration and ongoing pathologic reflux is evident in those patients with erosive esophagitis.
Innervation
The esophageal sensory innervation information is carried in the vagus and spinal nerves. The afferent nerve fibers can be classified by their terminal location in the esophagus. There are mucosal receptors that terminate in the subepithelium and muscle receptors that terminate deeper. Each can be further classified based on the sensory modality they convey including chemoreceptors, mechanoreceptors, and thermoreceptors. 22 Interestingly, most of these fibers are multimodal, meaning that they respond to both mechanical and chemical stimulation. 23, 24 One of the most important nociceptors in the esophagus is the nonselective calciumpermeable cation channel, transient receptor potential channel vanilloid subfamily member-1, which is discussed later.
Assessing the Epithelial Barrier Structure/Morphology
A detailed evaluation of the esophageal epithelial barrier structure is best performed on tissue samples obtained via biopsies, but there have been advancements in studying the structural aspects of the barrier both in vitro and in vivo. Light microscopy is a technique that can be used to assess the structural aspects of the barrier by using a multitude of staining options, including basic hematoxylin and eosin stain, periodic acid-Schiff staining, and silver staining ( Figure 2 ). This method of evaluation can show the basic cell layering and also provide information about intercellular space dilatation. This dilatation is commonly referred to as spongiosis. Unfortunately, light microscopy has a limited resolution of 200 nm, so dilatation can only be described qualitatively as spongiosis, whereas electron microscopy allows for quantitative assessment via its higher magnification.
An important development in the study of the apical junction complex has been the use of fluorescence microscopy with indirect and direct immunofluorescence. In the case of the apical junction complex, these techniques can be used to specifically target junctional proteins within the epithelium. This approach can help determine the presence or absence of the protein in the sample epithelium, and it also enables localization of the protein to a specific cell layer. Although this has been critical to understanding the epithelial barrier structure, it is limited by light microscopy's restricted resolution. Although this can be potentially overcome by fluorescence resonance energy transfer, a type of highresolution light microscopy, this has not been widely used in apical junction research.
Evaluation of the barrier structure in a higher degree of detail than what is achieved with light microscopy is possible through transmission electron microscopy (TEM). This is performed on sections of tissue that are 50-70 nm thick. Then, a beam of electrons are propelled through the specimen and detected by a sensor. The wavelength of electrons is smaller than that of visible light, allowing for vastly improved resolution. However, even with TEM, individual protein imaging is not possible but it can give a better sense of overall barrier structure given the resolution of approximately 0.2 nm.
One surrogate marker for barrier structure in the esophagus that has been widely reported in the literature is dilated intercellular spaces (Figure 3) . 11, [25] [26] [27] [28] There is no standard method for assessing intercellular space size. The most widely used method is to obtain photomicrographs of the tissue during microscopy and then measure the length of lines that are drawn perpendicularly to the neighboring membranes (obtained in microns). 28 Typically, 10 transects are drawn per 1 photomicrograph and an average is taken of these 10 measurements.
More recently, there has been interest in studying the barrier structure in vivo. A newer in vivo imaging technique is confocal laser-induced endomicroscopy (CLE). 29, 30 There were 2 main types of CLE: integrated CLE into the endoscope (eCLE, Pentax Medical, Tokyo, Japan), and probe-based (pCLE, Cellvizio, Mauna Kea Technologies, Paris, France). The former device is no longer in production, leaving pCLE as the only currently available technique. The pCLE probe can be passed through the biopsy channel of a standard diagnostic upper endoscope and held against the mucosa with gentle pressure to provide real-time endomicroscopy images. These imaging techniques use a low-power laser light at a 488 nm wavelength to illuminate tissue. This light is reflected by the tissue and then focused onto the detection system through a small aperture to construct a 2-dimensional grey-scale image. To enhance imaging, either topical (eg, creysl violet, acriflavin hydrochloride) or intravenous (eg, fluorescein sodium) contrast agents are used. It captures images at Â1000 magnification and at 12 frames per second thus providing live viewing. It has an imaging field of 240 mm and can scan at a fixed depth of 55-65 mm (Figure 4) . 31 pCLE has been studied more extensively in the small bowel and colon with a focus on inflammatory bowel disease and irritable bowel syndrome. However, there is 1 study that has shown that CLE can detect esophageal mucosal microalterations in patients with nonerosive reflux disease. [32] [33] [34] Using this technique, researchers have assessed epithelial barrier function via 3 methods: (1) fluorescein leak through the epithelium by measuring the diameter of the leak through the paracellular space, (2) cell shedding, and (3) microerosions. 35 Another way to quantitatively assess the barrier structure has been to count the number of epithelial gaps that result from epithelial cell shedding in 1 pCLE image. 36 The pCLE technique has also been used in the study of Barrett's esophagus (BE) to help identify BE and neoplasia based on endomicroscopy. 37 Beyond evaluating the barrier structure with imaging, investigators have recently been able to assess barrier structural components by measuring structural components in the serum. Given the solubility of the N-terminus of epithelial-cadherin, this can be measured in serum to assess for disruption in this protein. 38 Also, JAM-A has been detected in serum at higher levels in patients with head and neck squamous cell carcinoma. 39 
Assessing the Epithelial Barrier Function
Assessment of the esophageal barrier function can be done in vitro and in vivo. Unlike assessing structure, however, the study of esophageal barrier function is relatively easy in vivo when compared with in vitro. The historical basis for in vitro studies has relied on the Ussing chamber. This technique involves placing the epithelial tissue across an aperture that separates 2 chambers (into the "apical side" and "basal side") that are filled with a symmetrical solution. The resultant ion transfer from one side of the tissue to the other produces a voltage difference across the epithelium that is measured using electrodes on either side of the chamber and reported as TER. Dye-and molecule-based transfer measurements may also be made to assess the ability of molecules, such as fluorescein, to traverse the barrier as a measure of transmembrane flux. 40, 41 This technique, however, is technically challenging with several technical minutiae to be considered for a successful study.
In vivo study of the mucosal barrier function is easier and more efficient to perform. The basis for studying the barrier function in this setting is by measuring mucosal impedance (MI), which correlates with TER. This method measures MI by taking advantage of Ohm's law (V ¼ IR). With a fixed voltage (V) between 2 adjacent conductors that are in contact with the mucosa, more current (I) can pass through the mucosa when the tissue impedance (R) is low. This current is a surrogate for the charged ions and water that more easily traverses the tissue if barrier function is impaired. Interestingly, findings from MI correlate with structural changes in the mucosa as measured by dilated intercellular spaces that were described as spongiosis on light microscopy. 42 There are several tools that can be used to measure MI in vivo ( Figure 5 ). First is an endoscopically placed probe (Sandhill Scientific, Milwaukee, Wisconsin). This probe measures 2 mm in diameter and has 2 sensors at the distal end that are 3 mm in length and separated by 2 mm. 43 After the esophagus is suctioned of any retained secretions and free air, the probe is passed through the biopsy channel of a standard diagnostic upper endoscope, and the sensors are pressed against the mucosa in the esophagus. This initial step is required because free esophageal air results in a rise in impedance measurements, whereas liquid, such as reflux or swallowedsaliva, results in a drop in impedance. Once embedded in the mucosa, MI can be measured over a stable baseline period of approximately 15-30 seconds. In addition to this type of probe with the sensors arranged in bands, the electrical tissue impedance spectroscopy probe has 4 sensors in an end-on fashion that measure the same impedance. 44 Figure 4. pCLE image of the esophageal mucosa after intravenous fluorescein contrast injection in a patient with no pathologic reflux (left) and pathologic reflux (right).
Another method by which to measure MI is to use the standard combined multichannel intraluminal impedance and pH probe. This probe, with its impedance sensors, rests on the esophageal mucosal surface and in the absence of luminal fluid or air, typically recorded during the sleep period, can produce similar data to the endoscopically placed probe. There is also the advantage of studying multiple points in the esophagus simultaneously. A similar technique is to study the MI of the esophagus using baseline the impedance data measured before swallows during high-resolution impedance manometry. 45 With these different techniques, there exists some degree of variability in MI measurements depending on the modality as a result of different impedance sensor spacing; adequacy of contact with the mucosa; and the presence of air, liquids, or solids in the esophageal lumen. To reduce this variability, investigators have developed an endoscopically placed MI catheter that has the sensors mounted on a 10-cm-long balloon that can be inflated to displace any luminal contents and produce direct contact with the mucosa. 43 
Esophageal Epithelial Barrier in Disease
The esophageal mucosal barrier function is altered in many pathologic processes, including EoE, erosive and nonerosive reflux disease, and BE, as well in obesity.
Eosinophilic Esophagitis
This is an immune antigen-mediated disease of the esophagus wherein antigens in certain foods on exposure to the esophageal mucosa elicit a T-helper cell type 2 cascade. This subsequently leads to tissue eosinophilia, inflammation, and ultimately fibrosis. 46 Although it is theorized that antigens are recognized by the resident dendritic antigen-presenting cells in the mucosa, which leads to the inflammatory reaction, the exact mechanism remains unknown. It has been hypothesized that there are pathways by which immunogenic antigens penetrate the epithelial barrier as described previously to make contact with the dendritic cells. In EoE, evidence of barrier dysfunction is characterized by several types of data. For example, dilatation of intercellular spaces is a prominent feature of EoE histologic activity that that can be seen on both light and electron microscopy and improves with steroid and diet therapy. 11 There is also good correlation of reduction in tissue eosinophilia to spongiosis. In a recent study, spongiosis and tissue levels of several tight junction proteins were studied in EoE. Zonulin-3, claudin-1, and filaggrin, as measured with immunohistochemical staining, were prominent in normal esophageal tissue and in patients with EoE in histologic remission. In contrast, low levels of staining for these tight junction proteins occurred in active disease with improvement on steroid therapy. There was good inverse correlation of the level of tight junction protein staining to the degree of spongiosis seen. 11 The mechanism in EoE by which there is a reduction in these tight junction proteins is unclear, although the filaggrin gene, which is decreased in patients with EoE, encodes for the synthesis of filaggrin.
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Investigators have also shown abnormalities in the desmosomes in patients with EoE. For example, patients with active EoE have low levels of desmoglein-1 on Figure 5 . Endoscopically placed mucosal impedance probe (left) and a standard ambulatory combined multichannel intraluminal impedance and pH probe with several impedance sensors along the length of the esophagus (right).
biopsy. Furthermore, DSG1 silencing gene impairs epithelial integrity in an esophageal cell culture model. 48 Desmoglein dysfunction may be related to recent data demonstrating that IgG4 may be prominent in EoE. 49 In pemphigus vulgaris, IgG4 autoantibodies may inhibit desmoglein. 50 The structural changes within the adherens junction complex also correlate with changes in paracellular transit. Investigators have been able to show by using Ussing chambers that molecules of up to 40,000 Da passed through the mucosa in patients with EoE and proton-pump inhibitor (PPI)-responsive EoE (PPI-REE). 51 This size of molecule is similar to many food allergens. This same study also showed that those with EoE and PPI-REE had a significantly lower mean MI of 2014 U and 3128 U when compared with control subjects with a mean MI of 7707 U. All of these functional measurements were correlated with intercellular space with TEM and they observed an improvement of MI and intercellular space dilatation with treatment after PPI in the PPI-REE group. Other groups have also shown that treatment of EoE results in improved esophageal MI. 42 Finally, a recent study has demonstrated the presence of food antigen in the esophageal epithelium of patients with EoE. 52 In patients with active disease, increased levels of gliadin could be detected in the esophageal epithelium by immunofluorescent staining when compared with patients with inactive disease and control subjects. This study supports data documenting abnormal epithelial permeability in EoE allowing antigen entry as the first step in disease activation.
Further evidence for the barrier dysfunction in EoE comes from the improvement in barrier function that is seen with treatment. To date, there have been 2 studies showing improvement in both barrier structure and function. 42, 53 Gastroesophageal Reflux Disease Increased distal esophageal acid exposure documented during ambulatory pH monitoring has been considered the gold standard for diagnosing GERD. 54 On light microscopy, histologic evidence of GERD in the esophageal mucosa has included basal cell hyperplasia and increased height of the rete ridges, but these findings have limited diagnostic capability and are not reliable to prove the presence of GERD. 55 Using TEM, investigators have also documented dilated intercellular spaces as a sensitive marker in patients with GERD ( Figure 3) . 26, 27, [56] [57] [58] [59] [60] There are also data that show nonacidic reflux decreases mucosal claudin-3, -4, and epithelial-cadherin expression. 61 The dogma of GERD is that the luminal acid mediates injury via direct contact with the surface mucosal cells. It is only when these cells are damaged that they allow paracellular transit of acid to the vulnerable basolateral layer. However, emerging research suggests that the mucosal changes in GERD may be driven by a more generalized inflammatory process. In an animal model of GERD, epithelial injury persisted weeks after caustic exposure with elevation of interleukin-8. 62 Furthermore, in a recent study examining the recurrence of esophageal inflammation after stopping PPIs in patients with healed erosive esophagitis, the biopsy findings of increases in intraepithelial lymphocytes, widening of intercellular spaces, and basal cell and papillary hyperplasia developed without surface erosions. 63 In other words, the pattern of injury in patients with GERD may start in the basal layer and not the surface epithelium where caustic exposure occurs. Other supporting evidence for this comes from in vitro studies that showed when human esophageal squamous cells in culture were exposed to acidic bile salts, this resulted in production of proinflammatory cytokines (interleukin-8 and -1b) from the cells. 62 These proinflammatory cytokines then change the adherens junction complex protein composition to allow for increased paracellular transit. This is supported by TEM evidence of dilated intercellular spaces and decreased MI in patients with GERD. The decrease in MI has been corroborated with Ussing cambers. Using this technique, investigators have been able to show that tissue from patients with pathologic GERD had lower TER and greater fluorescein flux over a period of 2 hours when compared with those without GERD. 64 Investigators have also shown that TER is lower in rabbit esophageal tissue that has been exposed to bile salts and pepsin, which supports the hypothesis of why those with nonacidic reflux may have symptoms given increased paracellular permeability. 65 The change in paracellular permeability may also have a role in esophageal hypersensitivity. This is supported by studies showing that the mucosa of patients with nonerosive reflux has increased expression of transient receptor potential channel vanilloid subfamily member-1. 66, 67 This nonselective calcium-permeable cation channel, which exists in the esophageal submucosal nerve fibers, activates with exposure to hydrogen ions that penetrate through the dilated intercellular space and create the burning sensation. 68 Once activated, these channels also induce inflammation by releasing substance P, platelet-derived growth factor and calcitonin gene-related peptide. 69, 70 There are several factors that may affect the structures that maintain esophageal epithelial cell spaces and prevent reflux injury. For example, in a rat model estrogen pretreatment significantly attenuated the decrease in the transmembrane resistance and the increase in the epithelial permeability induced by acid perfusion in vitro. It also potentiated expression of occludin. Furthermore, the dilatation of the intercellular space induced by luminal HCl was significantly alleviated by 17b-estradiol administration. 71 As a result, one might speculate that this finding in part accounts for less severe reflux injury and/or risk of BE in women than in men.
Barrett's Esophagus BE, as defined by !1 cm of intestinal metaplasia above the gastroesophageal junction, is another pathologic condition that is associated with changes in the esophageal barrier function. Some theorize that a combination of GERD, which likely causes barrier dysfunction via a combination of chemical injury and from proinflammatory cytokines as mentioned previously, and other conditions that are associated with a proinflammatory state, such as central obesity, lead to dilated intercellular spaces and barrier dysfunction, which is susceptible to metaplasia. 27 Once BE has formed, the barrier structure resembles that of small bowel in that the intercellular space is dilated. 72 While the spaces are dilated, this form of mucosa may be better at defending against acid injury. Some theorize that the structural protein change, including the inclusion of claudin-18 in BE epithelium, which is essentially missing in normal squamous epithelium, enhances its resistance to paracellular acid transport. 63 In this study, they also described an increase in epithelial resistance. Other studies of BE claudin composition have shown that BE has more claudin-2 and claudin-3 and less claudin-1 and claudin-5 when compared with their control subjects. 73 Unfortunately, the increase in epithelial resistance as described in the first study previously is not consistent with the decreased MI associated with BE epithelium that we observe in our practice. This decrease that we observe in practice has been studied as a surrogate marker for dysplasia, where investigators have described the ability to detect a larger degree of dysplasia based on lower tissue resistance. 74 Also, studies have shown that baseline impedance, as measured with a manometry probe, are lower in patients with BE as one might expect in columnar mucosa. 75 This is likely a reflection of MI as opposed to intraluminal contents given that is was the baseline reading. Finally, even after successful ablative therapy for BE with radiofrequency ablation, the new squamous mucosa that forms in the treated area seems to exhibit decreased tissue resistance, which may reflect greater susceptibility to reflux-mediated injury. 76 
Obesity
Adipose tissue, particularly central/visceral adipose tissue, may impact the esophageal barrier structure and function. Although peripherally located adiposity is relatively inert from a metabolic standpoint, centrally located adiposity releases proinflammatory chemokines, such as tumor necrosis factor-a and interleukin-6, which have a range of deleterious effects from insulin resistance to cancer risk. [77] [78] [79] In regards to mucosal permeability, there are data showing that these proinflammatory chemokines alter the tight junction protein composition. 80 A good example of this is with the tight junction composition in active EoE. 11 It is unclear if central obesity as the only producer of these cytokines impacts the esophageal barrier function, but recent work has suggested that it may affect the barrier structure as evidenced by dilated intracellular spaces in patients with increased waist-to-hip ratios who did not have reflux documented by ambulatory pH monitoring ( Figure 3) . 27 Further studies are needed to see if central obesity alone impacts the barrier function.
Conclusions and Future Directions
Although substantial advances have been made in understanding the esophageal epithelial barrier, clinicians are far from comprehending all details of its regulation and function. Although it is known that paracellular permeability is at the heart of many disease states of the esophagus and that this is largely dictated by the proteins that maintain the intercellular space, there is no clear consensus on the balanced function of these regulatory proteins in the normal state or how underlying inflammatory disorders precisely lead to their dysfunction. This is evident in the evolving understanding of the complex relationship between GERD, PPI-REE, and EoE. With the existing investigation tools that can assess the mucosal superstructure with TEM and CLE, the composition of the adherens junction complex with immunohistochemical staining, and correlating this information with the in vitro and in vivo tools to measure paracellular permeability, the future is bright in further understanding the esophageal mucosal barrier in health and disease. Understanding these mechanisms could lead to therapies directed at repairing or preventing barrier dysfunction on a molecular basis or using this knowledge of barrier dysfunction to risk-stratify patients for different disease states.
